Skip to content 
The index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies. Under normal circumstances, the fund will obtain leveraged exposure to at least 80% of its total assets in components of the index or in instruments with similar economic characteristics. The fund is non-diversified. more
| Time Frame | BIB | S&P500 |
|---|---|---|
| 1-Week Return | 7.97% | -0.51% |
| 1-Month Return | 22.62% | 3.32% |
| 3-Month Return | 46.52% | 1.71% |
| 6-Month Return | 37.51% | 10.09% |
| 1-Year Return | 121.24% | 18.81% |
| 3-Year Return | 133.68% | 73.63% |
| 5-Year Return | 14.96% | 70.09% |
| 10-Year Return | 159.01% | 251.34% |
| Stock name | Ticker | Weight |
|---|---|---|
 Net Other Assets (Liabilities) | Net.Other.Assets..Liabilities. | 42.43% |
 PROSHARES GENIUS MNY MKT ETF | IQMM | 4.82% |
 AMGEN INC | AMGN | 4.65% |
 VERTEX PHARMACEUTICALS INC | VRTX | 4.32% |
 GILEAD SCIENCES INC | GILD | 3.85% |
 REGENERON PHARMACEUTICALS | REGN | 2.87% |
 MODERNA INC | MRNA | 1.85% |
 REVOLUTION MEDICINES INC | RVMD | 1.51% |
 ILLUMINA INC | ILMN | 1.14% |
 BIOGEN INC | BIIB | 1.08% |
 ALNYLAM PHARMACEUTICALS INC | ALNY | 1.06% |
 ARGENX SE - ADR | ARGX | 0.94% |
 ROYALTY PHARMA PLC- CL A | RPRX | 0.91% |
 INSMED INC | INSM | 0.9% |
 ROIVANT SCIENCES LTD | ROIV | 0.88% |
 INCYTE CORP | INCY | 0.86% |
 UNITED THERAPEUTICS CORP | UTHR | 0.73% |
 GUARDANT HEALTH INC | GH | 0.73% |
 VIATRIS INC | VTRS | 0.65% |
 MEDPACE HOLDINGS INC | MEDP | 0.59% |
 JAZZ PHARMACEUTICALS PLC | JAZZ | 0.54% |
 BRIDGEBIO PHARMA INC | BBIO | 0.53% |
 ASCENDIS PHARMA A/S | ASND | 0.52% |
 NEUROCRINE BIOSCIENCES INC | NBIX | 0.52% |
 EXELIXIS INC | EXEL | 0.46% |
 BIONTECH SE-ADR | BNTX | 0.44% |
 HALOZYME THERAPEUTICS INC | HALO | 0.43% |
 BIOMARIN PHARMACEUTICAL INC | BMRN | 0.42% |
 BEONE MEDICINES LTD-ADR | ONC | 0.41% |
 ARROWHEAD PHARMACEUTICALS IN | ARWR | 0.41% |
 MADRIGAL PHARMACEUTICALS INC | MDGL | 0.4% |
 TEMPUS AI INC-CL A | TEM | 0.39% |
 SANOFI-ADR | SNY | 0.36% |
 AXSOME THERAPEUTICS INC | AXSM | 0.36% |
 CYTOKINETICS INC | CYTK | 0.35% |
 PRAXIS PRECISION MEDICINES I | PRAX | 0.35% |
 IONIS PHARMACEUTICALS INC | IONS | 0.34% |
 KRYSTAL BIOTECH INC | KRYS | 0.34% |
 KYMERA THERAPEUTICS INC | KYMR | 0.34% |
 PROTAGONIST THERAPEUTICS INC | PTGX | 0.33% |
 SUMMIT THERAPEUTICS INC | SMMT | 0.33% |
 SPYRE THERAPEUTICS INC | SYRE | 0.31% |
 CRINETICS PHARMACEUTICALS IN | CRNX | 0.3% |
 VAXCYTE INC | PCVX | 0.3% |
 IMMUNOVANT INC | IMVT | 0.3% |
 TWIST BIOSCIENCE CORP | TWST | 0.29% |
 APOGEE THERAPEUTICS INC | APGE | 0.28% |
 ALKERMES PLC | ALKS | 0.27% |
 IMMUNITYBIO INC | IBRX | 0.27% |
 RHYTHM PHARMACEUTICALS INC | RYTM | 0.26% |
 10X GENOMICS INC-CLASS A | TXG | 0.25% |
 CARIS LIFE SCIENCES INC | CAI | 0.25% |
 SCHOLAR ROCK HOLDING CORP | SRRK | 0.23% |
 CG ONCOLOGY INC | CGON | 0.23% |
 ABIVAX SA-ADR | ABVX | 0.23% |
 COGENT BIOSCIENCES INC | COGT | 0.21% |
 ORUKA THERAPEUTICS INC | ORKA | 0.21% |
 TRAVERE THERAPEUTICS INC | TVTX | 0.2% |
 MIRUM PHARMACEUTICALS INC | MIRM | 0.2% |
 PTC THERAPEUTICS INC | PTCT | 0.2% |
 XENON PHARMACEUTICALS INC | XENE | 0.2% |
 AMNEAL PHARMACEUTICALS INC | AMRX | 0.19% |
 LIGAND PHARMACEUTICALS | LGND | 0.19% |
 CRISPR THERAPEUTICS AG | CRSP | 0.19% |
 ERASCA INC | ERAS | 0.18% |
 ACADIA PHARMACEUTICALS INC | ACAD | 0.17% |
 EDGEWISE THERAPEUTICS INC | EWTX | 0.16% |
 DEFINIUM THERAPEUTICS INC | DFTX | 0.16% |
 INDIVIOR PHARMACEUTICALS INC | INDV | 0.15% |
 DYNE THERAPEUTICS INC | DYN | 0.14% |
 AMYLYX PHARMACEUTICALS INC | AMLX | 0.14% |
 RELAY THERAPEUTICS INC | RLAY | 0.14% |
 ADAPTIVE BIOTECHNOLOGIES | ADPT | 0.14% |
 DENALI THERAPEUTICS INC | DNLI | 0.13% |
 STRUCTURE THERAPEUTICS INC | GPCR | 0.13% |
 ENLIVEN THERAPEUTICS INC | ELVN | 0.13% |
 KINIKSA PHARMACEUTICALS INTE | KNSA | 0.12% |
 IOVANCE BIOTHERAPEUTICS INC | IOVA | 0.12% |
 TANGO THERAPEUTICS INC | TNGX | 0.12% |
 IDEAYA BIOSCIENCES INC | IDYA | 0.12% |
 VERACYTE INC | VCYT | 0.11% |
 GRAIL INC | GRAL | 0.11% |
 ABCELLERA BIOLOGICS INC | ABCL | 0.11% |
 MBX BIOSCIENCES INC | MBX | 0.11% |
 NEWAMSTERDAM PHARMA CO NV | NEWAMSTERDAM.PHARMA.CO.NV | 0.11% |
 TARSUS PHARMACEUTICALS INC | TARS | 0.11% |
 ARCUTIS BIOTHERAPEUTICS INC | ARQT | 0.1% |
 DISC MEDICINE INC | IRON | 0.1% |
 UNIQURE NV | QURE | 0.1% |
 BEAM THERAPEUTICS INC | BEAM | 0.1% |
 ALUMIS INC | ALMS | 0.1% |
 ATAIBECKLEY INC | ATAI | 0.09% |
 NURIX THERAPEUTICS INC | NRIX | 0.09% |
 SUPERNUS PHARMACEUTICALS INC | SUPN | 0.09% |
 PHARVARIS NV | PHVS | 0.09% |
 TREVI THERAPEUTICS INC | TRVI | 0.09% |
 PRECIGEN INC | PGEN | 0.09% |
 ULTRAGENYX PHARMACEUTICAL IN | RARE | 0.09% |
 GENMAB A/S -SP ADR | GMAB | 0.08% |
 BIOCRYST PHARMACEUTICALS INC | BCRX | 0.08% |
 VERA THERAPEUTICS INC | VERA | 0.08% |
 RAPPORT THERAPEUTICS INC | RAPP | 0.08% |
 OCULAR THERAPEUTIX INC | OCUL | 0.08% |
 KODIAK SCIENCES INC | KOD | 0.08% |
 UROGEN PHARMA LTD | URGN | 0.08% |
 HARMONY BIOSCIENCES HOLDINGS | HRMY | 0.07% |
 ADMA BIOLOGICS INC | ADMA | 0.07% |
 VERICEL CORP | VCEL | 0.07% |
 XENCOR INC | XNCR | 0.07% |
 AURINIA PHARMACEUTICALS INC | AUPH | 0.07% |
 ZYMEWORKS INC | ZYME | 0.07% |
 MINERALYS THERAPEUTICS INC | MLYS | 0.07% |
 STOKE THERAPEUTICS INC | STOK | 0.07% |
 ZENAS BIOPHARMA INC | ZBIO | 0.07% |
 AGIOS PHARMACEUTICALS INC | AGIO | 0.07% |
 NOVOCURE LTD | NVCR | 0.07% |
 GH RESEARCH PLC | GHRS | 0.06% |
 SAREPTA THERAPEUTICS INC | SRPT | 0.06% |
 COMPASS PATHWAYS PLC | CMPS | 0.06% |
 SEPTERNA INC | SEPN | 0.06% |
 PERSONALIS INC | PSNL | 0.06% |
 LEGEND BIOTECH CORP-ADR | LEGN | 0.06% |
 ETON PHARMACEUTICALS INC | ETON | 0.06% |
 INTELLIA THERAPEUTICS INC | NTLA | 0.06% |
 SYNDAX PHARMACEUTICALS INC | SNDX | 0.06% |
 FORTREA HOLDINGS INC | FTRE | 0.06% |
 TAYSHA GENE THERAPIES INC | TSHA | 0.06% |
 RECURSION PHARMACEUTICALS-A | RXRX | 0.06% |
 ANAPTYSBIO INC | ANAB | 0.06% |
 ANI PHARMACEUTICALS INC | ANIP | 0.06% |
 VIR BIOTECHNOLOGY INC | VIR | 0.06% |
 MAZE THERAPEUTICS INC | MAZE | 0.06% |
 ALVOTECH SA | ALVO | 0.06% |
 IMMUNOCORE HOLDINGS PLC-ADR | IMCR | 0.05% |
 TYRA BIOSCIENCES INC | TYRA | 0.05% |
 INNOVIVA INC | INVA | 0.05% |
 BICARA THERAPEUTICS INC | BCAX | 0.05% |
 INHIBRX BIOSCIENCES INC | INBX | 0.05% |
 XERIS BIOPHARMA HOLDINGS INC | XERS | 0.05% |
 FIRST TRACKS BIOTHERAPEUTICS | TRAX | 0.05% |
 HARROW INC | HROW | 0.05% |
 NOVAVAX INC | NVAX | 0.05% |
 OMEROS CORP | OMER | 0.05% |
 ORIC PHARMACEUTICALS INC | ORIC | 0.05% |
 ABSCI CORP | ABSI | 0.05% |
 MEIRAGTX HOLDINGS PLC | MGTX | 0.05% |
 CULLINAN THERAPEUTICS INC | CGEM | 0.05% |
 ARRIVENT BIOPHARMA INC | AVBP | 0.04% |
 MANNKIND CORP | MNKD | 0.04% |
 MARAVAI LIFESCIENCES HLDGS-A | MRVI | 0.04% |
 VOR BIOPHARMA INC | VOR | 0.04% |
 REPLIMUNE GROUP INC | REPL | 0.04% |
 CORVUS PHARMACEUTICALS INC | CRVS | 0.04% |
 MONTE ROSA THERAPEUTICS INC | GLUE | 0.04% |
 SAVARA INC | SVRA | 0.04% |
 JANUX THERAPEUTICS INC | JANX | 0.04% |
 KURA ONCOLOGY INC | KURA | 0.04% |
 SANA BIOTECHNOLOGY INC | SANA | 0.04% |
 ARBUTUS BIOPHARMA CORP | ABUS | 0.03% |
 CASTLE BIOSCIENCES INC | CSTL | 0.03% |
 WAVE LIFE SCIENCES INC | WVE | 0.03% |
 PACIRA BIOSCIENCES INC | PCRX | 0.03% |
 GERON CORP | GERN | 0.03% |
 GRIFOLS SA-ADR | GRFS | 0.03% |
 DESIGN THERAPEUTICS INC | DSGN | 0.03% |
 AMPHASTAR PHARMACEUTICALS IN | AMPH | 0.03% |
 CANDEL THERAPEUTICS INC | CADL | 0.03% |
 ARDELYX INC | ARDX | 0.03% |
 OLEMA PHARMACEUTICALS INC | OLMA | 0.03% |
 SOLID BIOSCIENCES INC | SLDB | 0.03% |
 COLLEGIUM PHARMACEUTICAL INC | COLL | 0.03% |
 ACLARIS THERAPEUTICS INC | ACRS | 0.03% |
 THERAVANCE BIOPHARMA INC | TBPH | 0.03% |
 MESOBLAST LTD- SPON ADR | MESO | 0.03% |
 ZAI LAB LTD-ADR | ZLAB | 0.03% |
 RIGEL PHARMACEUTICALS INC | RIGL | 0.03% |
 ANNEXON INC | ANNX | 0.03% |
 AURA BIOSCIENCES INC | AURA | 0.03% |
 4D MOLECULAR THERAPEUTICS IN | FDMT | 0.03% |
 PHIBRO ANIMAL HEALTH CORP-A | PAHC | 0.03% |
 CYTOMX THERAPEUTICS INC | CTMX | 0.02% |
 ALLOGENE THERAPEUTICS INC | ALLO | 0.02% |
 PHATHOM PHARMACEUTICALS INC | PHAT | 0.02% |
 TECTONIC THERAPEUTIC INC | TECX | 0.02% |
 ZEVRA THERAPEUTICS INC | ZVRA | 0.02% |
 OMNIAB INC | OABI | 0.02% |
 IRONWOOD PHARMACEUTICALS INC | IRWD | 0.02% |
 CORMEDIX INC | CRMD | 0.02% |
 NEUROGENE INC | NGNE | 0.02% |
 SAGIMET BIOSCIENCES INC-A | SGMT | 0.02% |
 SILENCE THERAPEUTICS PLC-ADR | SLN | 0.02% |
 ALTIMMUNE INC | ALT | 0.02% |
 ARVINAS INC | ARVN | 0.02% |
 AQUESTIVE THERAPEUTICS INC | AQST | 0.02% |
 PRIME MEDICINE INC | PRME | 0.02% |
 EVOLUS INC | EOLS | 0.02% |
 CONTINEUM THERAPEUTICS INC-A | CTNM | 0.02% |
 ARS PHARMACEUTICALS INC | SPRY | 0.02% |
 CABALETTA BIO INC | CABA | 0.02% |
 KYVERNA THERAPEUTICS INC | KYTX | 0.02% |
 PROTHENA CORP PLC | PRTA | 0.02% |
 KAMADA LTD | KMDA | 0.02% |
 AUTOLUS THERAPEUTICS PLC | AUTL | 0.02% |
 PUMA BIOTECHNOLOGY INC | PBYI | 0.02% |
 EDITAS MEDICINE INC | EDIT | 0.02% |
 C4 THERAPEUTICS INC | CCCC | 0.02% |
 ATEA PHARMACEUTICALS INC | AVIR | 0.01% |
 LAKEFRONT BIOTHERAPEUTIC-ADR | LKFT | 0.01% |
 LARIMAR THERAPEUTICS INC | LRMR | 0.01% |
 BIOAGE LABS INC | BIOA | 0.01% |
 REGENXBIO INC | RGNX | 0.01% |
 ENANTA PHARMACEUTICALS INC | ENTA | 0.01% |
 EYEPOINT INC | EYPT | 0.01% |
 ARCTURUS THERAPEUTICS HOLDIN | ARCT | 0.01% |
 FOGHORN THERAPEUTICS INC | FHTX | 0.01% |
 PACIFIC BIOSCIENCES OF CALIF | PACB | 0.01% |
 ALPHA TEKNOVA INC | TKNO | 0.01% |
 LEXEO THERAPEUTICS INC | LXEO | 0.01% |
 ROCKET PHARMACEUTICALS INC | RCKT | 0.01% |
 UPSTREAM BIO INC | UPB | 0.01% |
 LYELL IMMUNOPHARMA INC | LYEL | 0.01% |
 IMMUNEERING CORP - CLASS A | IMRX | 0.01% |
 ORCHESTRA BIOMED HOLDINGS IN | OBIO | 0.01% |
 VANDA PHARMACEUTICALS INC | VNDA | 0.01% |
 AC IMMUNE SA | ACIU | 0.01% |
 ANAVEX LIFE SCIENCES CORP | AVXL | 0.01% |
 ENTRADA THERAPEUTICS INC | TRDA | 0.01% |
 NEUMORA THERAPEUTICS INC | NMRA | 0.01% |
 INVIVYD INC | IVVD | 0.01% |
 FULCRUM THERAPEUTICS INC | FULC | 0.01% |
 SIONNA THERAPEUTICS INC | SION | 0.01% |
 PEPGEN INC | PEPG | 0.01% |
 KEROS THERAPEUTICS INC | KROS | 0.01% |
 NOVABRIDGE BIOSCIENCES | NBP | 0.01% |
 SIGA TECHNOLOGIES INC | SIGA | 0.01% |
 COHERUS ONCOLOGY INC | CHRS | 0.01% |
 VOYAGER THERAPEUTICS INC | VYGR | 0.01% |
 BICYCLE THERAPEUTICS PLC-ADR | BCYC | 0.01% |
 PYXIS ONCOLOGY INC | PYXS | 0.01% |
 LIFECORE BIOMEDICAL INC | LFCR | 0.01% |
 JYONG BIOTECH LTD | MENS | 0.01% |
 CARIBOU BIOSCIENCES INC | CRBU | 0.01% |
 QUANTUM-SI INC | QSI | 0.01% |
 CODEXIS INC | CDXS | 0.01% |
 AARDVARK THERAPEUTICS INC | AARD | 0.01% |
 HUMACYTE INC | HUMA | 0% |
 TENAYA THERAPEUTICS INC | TNYA | 0% |
 LENZ THERAPEUTICS INC | LENZ | 0% |
 BLACK DIAMOND THERAPEUTICS I | BDTX | 0% |
 RANI THERAPEUTICS HOLDINGS-A | RANI | 0% |
 GOSSAMER BIO INC | GOSS | 0% |
 NASDAQ Biotechnology Index SWAP UBS AG | NASDAQ.Biotechnology.Index.SWAP.UBS.AG | 0% |
 THIRD HARMONIC BIO INC | THRD | 0% |
 NASDAQ Bio Index SWAP BNP Paribas | NASDAQ.Bio.Index.SWAP.BNP.Paribas | 0% |
 CARTESIAN THERAPEUTICS-CVR | CARTESIAN.THERAPEUTICS.CVR | 0% |
 NASDAQ Biotechnology Index SWAP Citibank NA | NASDAQ.Biotechnology.Index.SWAP.Citibank.NA | 0% |
 NASDAQ Biotechnology Index SWAP Bank of America NA | NASDAQ.Biotechnology.Index.SWAP.Bank.of.America.NA | 0% |
 NASDAQ Biotechnology Index SWAP Societe Generale | NASDAQ.Biotechnology.Index.SWAP.Societe.Generale | 0% |
 NASDAQ Biotechnology Index SWAP Goldman Sachs International | NASDAQ.Biotechnology.Index.SWAP.Goldman.Sachs.International | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
ProShares Ultra Nasdaq Biotechnology (BIB) share price today is $125.1901.
Yes, Indians can buy shares of ProShares Ultra Nasdaq Biotechnology (BIB) on Vested. To buy BIB from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of ProShares Ultra Nasdaq Biotechnology (BIB) on Vested. You can start investing in ProShares Ultra Nasdaq Biotechnology (BIB) with a minimum investment of $1.
The 52-week high price of ProShares Ultra Nasdaq Biotechnology (BIB) is $126.4. The 52-week low price of ProShares Ultra Nasdaq Biotechnology (BIB) is $54.58.
The stock symbol (or ticker) of ProShares Ultra Nasdaq Biotechnology is BIB.
Yes, you can setup SIP in ProShares Ultra Nasdaq Biotechnology shares. Follow the below steps to create the SIP:
Here is the historical performance of BIB on the Vested app.
The expense ratio of ProShares Ultra Nasdaq Biotechnology (BIB) is 0.95%.
Link copied 
